Saulius Diktanas

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S Koirala, Borisov Se, Edvardas Danila et al. · Pulmonology · 2021 · 47 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

Nicolás Casco, Alberto Levi Jorge, Domingo Palmero et al. · European Respiratory Journal · 2023 · 32 citations · Full text

Public Health, Health Sciences, Infectious Diseases +14

Factors Associated with Persistent Sputum Positivity at the End of the Second Month of Tuberculosis Treatment in Lithuania

Saulius Diktanas, Edita Vasiliauskienė, Katažyna Polubenko et al. · Tuberculosis & respiratory diseases · 2018 · 24 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

Oleksandr Korotych, Jay Achar, Elmira Gurbanova et al. · The Lancet Infectious Diseases · 2024 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16